Maternal Obesity and the Early Origins of Childhood Obesity: Weighing Up the Benefits and Costs of Maternal Weight Loss in the Periconceptional Period for the Offspring by Zhang, Song et al.
Hindawi Publishing Corporation
Experimental Diabetes Research
Volume 2011, Article ID 585749, 10 pages
doi:10.1155/2011/585749
Review Article
Maternal Obesityand theEarlyOriginsofChildhood
Obesity:WeighingUp the Beneﬁts and Costs of Maternal Weight
Loss in the Periconceptional Period for the Offspring
Song Zhang, LeewenRattanatray,Janna L. Morrison, Lisa M. Nicholas,
Shervi Lie, andI. CarolineMcMillen
Sansom Institute for Health Research, School of Pharmacy and Medical Sciences, University of South Australia, Adelaide,
SA 5001, Australia
Correspondence should be addressed to I. Caroline McMillen, caroline.mcmillen@unisa.edu.au
Received 28 June 2011; Revised 21 August 2011; Accepted 23 August 2011
Academic Editor: Christine Maric-Bilkan
Copyright © 2011 Song Zhang et al. This is an open access article distributed under the Creative Commons Attribution License,
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
There is a need to understand the separate or interdependent contributions of maternal prepregnancy BMI, gestational weight
gain, glycaemic control, and macronutrient intake on the metabolic outcomes for the oﬀspring. Experimental studies highlight
that there may be separate inﬂuences of maternal obesity during the periconceptional period and late gestation on the adiposity of
the oﬀspring. While a period of dietary restriction in obese mothers may ablate the programming of obesity, it is associated with
an activation of the stress axis in the oﬀspring. Thus, maternal obesity may result in epigenetic changes which predict the need for
eﬃcient fat storage in postnatal life, while maternal weight loss may lead to epigenetic changes which predict later adversity. Thus,
development of dietary interventions for obese mothers during the periconceptional period requires a greater evidence base which
allows the eﬀective weighing up of the metabolic beneﬁts and costs for the oﬀspring.
1.Introduction
As the prevalence of obesity has increased in the developed
world,morewomenareenteringpregnancywithahighbody
mass index (BMI) in the overweight (BMI > 25kg/m2)o r
obese (BMI > 30kg/m2) range. As discussed in this paper,
clinical and population studies have shown that maternal
obesityresultsinfertilityproblemsandsuboptimaloutcomes
for the mother and her fetus during and after pregnancy [1].
It is also the case that maternal obesity is associated with an
increase in BMI in the oﬀspring during infancy, childhood,
andlaterlife.ArecentscientiﬁcstatementfromtheAmerican
Heart Association Council on Epidemiology and Prevention
included a summary of the evidence for the prenatal
determinants of obesity and highlighted that “obesity among
girlsandwomenofchildbearingageisproducingaconcomitant
increase in rates of gestational diabetes which in turn is likely
to lead to more obesity in the next generation. This vicious
cycle may well fuel the obesity epidemic for decades to come”
[2]. This places a focus on the nutritional health of women
before pregnancy and on the development of optimal weight
loss interventions in overweight or obese women in the
preconceptional period to improve pregnancy outcomes.
This paper highlights recent evidence that suggests that the
periconceptional period may represent a critical window
during which exposure of the oocyte and/or embryo can
independently contribute to an increased risk of obesity in
the oﬀspring. Further, this paper summarises evidence from
experimental studies of the potential metabolic beneﬁts and
costs of weight loss during the periconceptional period in
overweight and obese mothers for the oﬀspring.
2.MaternalPrepregnancyBMI,Gestational
Weight Gain,andPregnancyOutcomes
During the past decade, the obesity epidemic in the devel-
oped world has resulted in an increase in the number of
women entering pregnancy with a high body mass index
(BMI) in the overweight (BMI > 25kg/m2) or obese (BMI >
30kg/m2)range.IntheUS,UK,andAustralia,theprevalence
of obesity in women aged between 20 and 39 years is around2 Experimental Diabetes Research
28%, 20%, and 15%, respectively, as determined in studies
carried out between 2000 and 2009 [1–5]. In the US, La
Coursiere and colleagues [6] found that the incidence of
women being either overweight or obese at the start of
pregnancy increased from 25% to 35% between 1991 and
2001, and that the incidence of maternal obesity at delivery
rose from 29% to 39% across the same period [6]. Although
the proportion of women of reproductive age in the US who
are overweight or obese appears to have plateaued recently,
the proportion that is severely obese (BMI ≥ 40kg/m2)
is increasing. Similarly, two recent reports from diﬀerent
states in Australia found that the prevalence of maternal
overweight and obesity was 34% in a population giving
birth between 1998 and 2002 and 43% in a population
measured at their ﬁrst antenatal visit between 2001 and 2005
[7, 8]. Obese women are at increased risk of a range of
pregnancycomplicationsincludinggestationalhypertension,
preeclampsia, gestational diabetes mellitus (GDM), delivery
of a large-for-gestational-age (LGA) infant, and an increase
in Caesarean section rate [9].
In addition to the focus on the impact of maternal
prepregnancy BMI on pregnancy outcomes, there has been a
rangeofobservationalstudieswhichsuggestthatthereisalso
an association between gestational weight gain with short-
and longer-term maternal outcomes [10]. The Institute
of Medicine (IOM) in the US has recently revised its
1990 guidelines for gestational weight gain in underweight,
normal weight, overweight, and obese women [11]. The new
guidelines were developed based on a systematic evidence-
based review [12] which found that the evidence that
gestational weight gain was related to maternal pregnancy
and postpartum outcomes was weak. There was, however,
a moderate association between gestational weight gain and
both Caesarean section delivery and maternal postpartum
weight retention [12]. Some recent observational studies in
obese women report better pregnancy outcomes at lower
or negative gestational weight gains than in the revised
IOM guidelines [10], but there are concerns that striving
to achieve a lower gestational weight gain than that recom-
mended in the new guidelines may have adverse outcomes
[1]. The recent International Life Sciences Institute (ILSI)
Europe Workshop on obesity in pregnancy concluded that
given that the new IOM guidelines were based on obser-
vational studies, there was a pressing requirement for large
randomised control trials which are adequately powered to
test the validity of the recommendations [1]. Currently, it
appears that for obese women, prepregnancy BMI is more
associated with an increased risk of preeclampsia, GDM,
and the delivery of an LGA infant than is gestational weight
gain [9]. This places a focus on the nutritional health of
women in the preconceptional period and on what weight
loss interventions can be safely introduced in the obese
woman seeking to become pregnant.
3.MaternalPrepregnancyBMI, Gestational
WeightGain,andChildhood Obesity
While it is not unexpected that the maternal nutritional
and hormonal environment would determine fetal nutrient
supply, fetal growth, and the body composition of the
infant,theeﬀectsofthenutritionalenvironmentexperienced
in utero persist beyond fetal life. There is a U-shaped
relationship between birth weight, and adult fat mass, with
a higher prevalence of adult obesity occurring in individuals
with birth weights at either the low or high end of the
birth weight distribution [13–16]. A study in a large British
cohort found that babies who were in the heaviest quintile
of birth weight tended to have a high BMI in adult life
independent of gender and that this relationship was largely
accounted for by maternal weight [15]. A recent Danish
study of 300,000 children also reported a remarkably stable
associationbetweenhavingabirthweightgreaterthan4000g
and being overweight at 6–13 years of age in both girls and
boys [17]. A retrospective US study of 8494 low-income
families found that children (both boys and girls) born to
obese mothers were twice as likely to be obese by 2 years
of age [16]. There was a greater than 2-fold increase in the
prevalence of obesity observed in children of obese mothers
compared to those with mothers whose BMI was in the
normal range.
Recent studies have investigated how a high maternal
prepregnancy BMI, poor maternal glycaemic control, and
total gestational weight gain may each contribute to a range
of outcomes including an LGA baby and child obesity. In one
report, siblings born to women who had undergone bariatric
surgery for the treatment of severe obesity had a lower BMI
and obesity risk than their siblings who were born prior to
maternal surgery and weight loss [18]. In this latter study,
it was not possible, due to the sample size, to determine
whethertherewasany diﬀerence in the impact of a reduction
in maternal weight on the metabolic outcomes in the male
or female oﬀspring. The ﬁndings of this latter study suggest
that exposure to a high maternal BMI before and during
pregnancy has important consequences for the metabolic
health of the oﬀspring. While some observational studies
have found that there is an impact of gestational weight gain
on outcomes including child obesity, the eﬀect of gestational
weight gain, independent of maternal prepregnancy BMI on
oﬀspring obesity, is not clear [10].
A high prepregnancy BMI is also associated with an
increased risk of poor glucose tolerance and GDM, and
recent randomised control trials provide evidence that there
is a causal relationship between maternal glucose intolerance
and the delivery of a macrosomic infant [19, 20]. A study
on Pima Indians reported that there was an increased risk of
obesity in oﬀspring (male and female) born after the mother
was diagnosed with diabetes compared with their siblings
who were born before the mothers were diagnosed with
diabetes [21]. Thus, exposure to an increase in high maternal
glucose and insulin concentrations from conception results
in a larger and fatter infant who is at increased risk of
obesity in later life. Interestingly in a recent follow-up study
of children whose mothers participated in a randomised
control trial, treatment of mild GDM resulted in a reduction
in macrosomia at birth but not in the BMI of oﬀspring at 4-5
years of age [22] .W h i l et h i sn u l le ﬀect may be a consequence
of the early age at which the children were studied, it is
also possible that there are separate eﬀects of exposure toExperimental Diabetes Research 3
GDM on fetal body growth and on the risk of increased
adiposity in childhood. In this context, it is of note that
maternal pre pregnancy weight and the associated level of
maternal insulin resistance are strongly correlated with an
infant’sfatmassatbirth,whereasthelevelofmaternalinsulin
resistance in later pregnancy is correlated with birth weight
and an infant’s “fat-free” mass [23]. Thus, better glycaemic
control in later pregnancy may have a greater impact on
infant body growth than on the propensity for childhood
obesity. Similarly, other studies have shown that there appear
to be independent contributions of maternal pre pregnancy
weight and maternal glucose intolerance during pregnancy
to birth weight and the risk of adolescent obesity [24].
Finally, the role of maternal macronutrient and energy
intakes during pregnancy on the subsequent development
of appetite and food choices of her oﬀspring has also been
investigated. Maternal glucose concentrations are inﬂuenced
by her total energy intake and by the proportions of
carbohydrate, fat, and protein in her diet. A recent study
investigated the association of maternal macronutrient and
energy intake during pregnancy with the macronutrient and
energy intake of her oﬀspring [25]. Maternal dietary intakes
ofprotein,fat,andcarbohydrateinpregnancywerepositively
associated with the dietary intake of the same nutrients in
both male and female oﬀspring, and these associations were
greater than those observed for paternal dietary intakes [25].
Furthermore, associations of maternal prenatal-oﬀspring
intakes were stronger than those for maternal postnatal-
oﬀspring intakes for protein and fat [25]. Thus, this study
supports the conclusion which has also been drawn from
a range of experimental animal studies as cited below, that
there may be in utero programming of oﬀspring appetite by
maternal intake during pregnancy in the human.
4. Maternal Overnutrition: Critical Periods for
the Development of PostnatalObesity
There is a need to understand the separate or interdependent
contributions of maternal pre pregnancy BMI, gestational
weight gain, glycaemic control, and maternal macronutrient
intake on the longer-term metabolic outcomes for
the oﬀspring, including the metabolic responses to an
obesogenic diet. This understanding would help inform
the evidence base for eﬀective nutritional interventions in
women before and during pregnancy. It is clearly diﬃcult
in human populations to determine the impact of exposure
to a high maternal BMI during the preconceptional period
separately from exposure to a high maternal BMI during any
subsequent stage of pregnancy on the metabolic outcomes
for the oﬀspring. Most women who enter pregnancy heavy
remain so during pregnancy and are also at greater risk of
development of glucose intolerance during late gestation.
A range of experimental animal studies have provided
insights into the mechanisms that may underpin the early
programming of a life of obesity, but as highlighted below
there are relatively few experimental studies which have
addressed the impact of maternal dietary interventions
imposed during diﬀerent periods of pregnancy on the
metabolic outcomes for the oﬀspring.
5. Animal Models of MaternalOvernutrition
5.1. The Early Programming of Obesity in the Rodent. The
eﬀects of obesity on oocyte quality and early embryo
development have been assessed by Minge and colleagues
using a mouse model of diet-induced obesity [26]. Embryos
isolated from either obese or control-mated females were
cultured in vitro in order to monitor their development.
Although a diﬀerence in fertilisation rates was not observed,
embryos from obese females exhibited slower development
to the four- to eight-cell stage and through to the blastocyst
stage. It was also reported in this study that defects in oocyte
developmental competence caused by obesity were reversed
by treatment with insulin sensitisers before conception.
Thus, maternal obesity and peripheral insulin sensitivity
are important from as early as the preconceptional period
in determining developmental outcomes. This is important
in the context that most animal models of maternal over-
nutrition include exposure to an increase in energy intake
and/or a diet which is high in fat and/or sugar including
exposure to “junk food” style diets from before conception
and throughout pregnancy [27–31].
There have been several excellent recent papers of the
impact of maternal overnutrition in rodents on the postnatal
metabolic phenotype of the pups and oﬀspring in later
life [32–34]. In most instances, it has been reported that
maternal overnutrition in the rat leads to a consistent
increase in body fat mass, poor glucose tolerance, insulin
resistance, and an increase in appetite in the oﬀspring [32–
35]. These studies provide important information on the
metabolic signalling pathways that are perturbed in skeletal
muscle, liver, and in visceral and subcutaneous adipose
tissue. Interestingly, however, a recent systematic paper of
those animals models which have used exposure to maternal
high-fat feeding throughout pregnancy identiﬁed that there
was a paucity of data which characterised what aspects of
the maternal metabolic state were related to the speciﬁc
postnatal outcomes. The authors of this paper commented
that this limited the capacity to draw links between the
maternal phenotype and the metabolic outcomes in the
oﬀspring in these models [36]. Important outcomes from
this systematic paper were ﬁrstly that all oﬀspring born to
obese mothers had perturbed glycaemic control in postnatal
life and secondly that poor glycaemic control was also
observed in oﬀspring from nonobese, high-fat-fed mothers
[36]. Importantly, there was not convincing evidence that
there was a hyperphagic phenotype in oﬀspring exposed
to a maternal diet which was high in fat and low in
carbohydrate [36]. In contrast, there is consistent evidence
for a hyperphagic phenotype in oﬀspring exposed to a
maternal diet that is high in sugar including “junk food”
and cafeteria-style diets [27–31]. This is consistent with a
wide range of studies in the rodent that have reported that
exposure of the fetal and neonatal brain to conditions in
which there is hyperglycaemia, hyperinsulinaemia, and/or
hyperleptinaemiacanresultintheprogrammingofpostnatal
appetite [37].
One important study determined the impact of feeding
nonpregnant rats with 15% excess calories/day for 3 weeks4 Experimental Diabetes Research
prior to mating such that dams entered pregnancy obese
or lean [38]. After mating, the dams were all placed on the
same diet for the remainder of pregnancy, and the pups were
cross-fostered at birth to normal-weight mothers to ensure
that the nutritional intervention was restricted to pregnancy.
Oﬀspring from the obese dams gained greater body weight
and had a higher percentage body fat than the oﬀspring from
lean dams when fed a high-fat diet in postnatal life. While
thenutritionalinterventioninthisstudywasrestrictedtothe
3-week period prior to conception, the dams which entered
pregnancy obese remained obese throughout pregnancy,
and the increase in oﬀspring adiposity might therefore
reﬂect the impact of overnutrition and obesity in both the
periconceptional period and the remainder of of pregnancy.
Another key study placed obese female rats on a control
chow diet from one month before mating for the remainder
of pregnancy and lactation and compared the outcomes
with those from obese female rats maintained on a high
fat diet from before and during pregnancy and throughout
lactation [39]. At 21 days after birth, serum triglycerides,
leptin and insulin were increased in the oﬀspring from the
obese mother on a high fat diet, but not the oﬀspring of
the obese mother fed on the control diet. An increase in
body fat mass in the oﬀspring of high fat fed mothers at
5 months of age was partially “reversed” in oﬀspring of
the chow fed, previously obese mothers [39]. This study
demonstrates the eﬀectiveness of a weight loss intervention
w h i c he x t e n d sf r o mb e f o r ea n dt h r o u g h o u tp r e g n a n c y .I ti s
not possible, however, to conclude whether the impact of
the dietary intervention on the previously obese rat was a
consequence of the decrease in her pre pregnancy weight and
fat mass, gestational weight gain, or exposure to a high-fat
diet during lactation.
5.2. The Early Programming of Obesity in the Sheep. There
have been a range of studies using the sheep as a large animal
model of pregnancy on the impact of exposure to maternal
obesity on the fetal and postnatal lamb. The sheep is an
excellent model for the study of the early development of
later obesity. In the sheep, as in the human, the development
of adipose tissue and of the hypothalamic neural network
whichregulatesappetiteandenergybalanceinlaterlifeoccur
beforebirth.Thisisunliketherodent,wherefatdevelopment
and the appetite regulatory system in the hypothalamus
each develop after birth [37, 40]. In an important series
of studies, it has been reported that exposure of ewes to
a diet containing 150% metabolic requirements from 60
daysbeforeconceptionandextendingthroughoutpregnancy
resulted in changes in adipose tissue development, glucose
tolerance, and appetite regulation in the adult oﬀspring [41].
In these studies, the adult oﬀspring from obese and control-
fed mothers were exposed to a 3-month “feeding challenge.”
During the feeding challenge, oﬀspring from obese ewes
consumed more food and at the end of the challenge had
a higher percentage of body fat than oﬀspring from control
ewes. There was also a decrease in insulin sensitivity in
the oﬀspring from obese ewes compared with their control
counterparts [41]. In this study, body fat mass was measured
using dual X-ray absorptiometry, and so it was not possible
to determine whether the increase in body fat mass after the
feeding challenge was a result of an increase in the visceral or
subcutaneous fat depots.
We have developed a model of maternal overnutrition
in which pregnant ewes were overfed for the last month
of pregnancy to determine whether exposure of the fetus
to increased maternal glucose concentrations during late
pregnancy would result in an increase in postnatal adiposity
[42–44]. We found that maternal overnutrition imposed in
this period resulted in an increase in fetal glucose and insulin
concentrations and an upregulation of key adipogenic and
lipogenic genes, including peroxisome-proliferator activator
receptor γ (PPAR γ), leptin, and adiponectin within the
perirenal fat depot of the late gestation sheep fetus [44]. We
alsofound that therewasan increased mass of subcutaneous,
but not visceral fat present in the male and female lambs
of these overnourished ewes at one month of age [42].
Furthermore, in the lambs of overnourished ewes, there
was a decrease in the hypothalamic expression of the leptin
receptor with increasing body fat mass and a loss of the pos-
itive relationship between the expression of a hypothalamic
appetite inhibitory peptide (cocaine amphetamine-regulated
transcript) and body fat mass [42].
Thus, it appears that exposure to maternal and fetal
hyperglycaemia in late pregnancy alone can result in an
increase in adiposity and in changes in the hypothalamic
neural network which would limit the appropriate response
to an increase in body fat mass and energy intake in the
postnatal animal.
Relatively few animal studies have attempted to deter-
mine the impact of maternal obesity restricted to the
“periconceptional period” alone on the development of
adiposity in the oﬀspring. The periconceptional period is
an important period for intervention because as highlighted
earlier there appears to be an association between maternal
pre pregnancy BMI and an increased body fat mass in the
oﬀspring. Furthermore, dietary intervention in overweight
or obese women is relatively more feasible in the pre- or
periconceptional period.
5.2.1. Deﬁnition of What Constitutes the “Periconceptional
Period”. The periconceptional period includes the period
extending from oocyte maturation to early gestation. In a
number of studies in the sheep, nutritional interventions
are imposed during a periconceptional period which extends
fromaround60daysbeforeto30daysafterconceptionwhich
covers the period of oocyte maturation, implantation, and
placentation[45,46].Nutritionalinterventionswhichextend
into the placentation period may aﬀect placental growth
and the placental transfer eﬃciency of substrates to the
f e t u sd u r i n ge a r l yo rl a t ep r e g n a n c y[ 47]. We have proposed
therefore that the term “periconceptional” should be used to
refer to the developmental stages which include some or all
of the following early events: oocyte maturation, follicular
development, conception, and embryo/blastocyst growth
up until implantation [48]. When maternal nutritional
interventions extend beyond implantation to include earlyExperimental Diabetes Research 5
placentation, then it may be more appropriate to describe
these interventions as occurring during “early gestation.”
5.2.2. Exposure to Maternal Overnutrition in the Pericon-
ceptional Period and Programming of Later Obesity in the
Sheep. We have developed a model in which nonpregnant
ewes were either overnourished or normally nourished
for at least 4 months before artiﬁcial insemination [49,
50]. In two subgroups of non pregnant ewes, a 4-week
period of dietary restriction was imposed before and after
artiﬁcial insemination to result in 4 periconceptional treat-
ment groups: periconceptional overnutrition with (HR) or
without (HH) dietary restriction and control nutrition with
(CR) or without (CC) dietary restriction [49]. Around a
week after conception, single embryos were transferred from
these donor ewes to nonobese recipient ewes which were
then maintained on a control diet for the remainder of
pregnancy. The ewes which were overnourished during the
periconceptional period were heavier than the control ewes
during this period (Figure 1). Recipient nonobese ewes were
maintained at a normal body condition score from the start
of the donor ewe feeding regime to the time of conception.
This model therefore isolates the eﬀect of exposure to
maternal obesity during the periconceptional period alone.
We found that there was a gender-speciﬁc eﬀect of
periconceptional overnutrition on the body fat mass of the
4-month-old lambs. Periconceptional overnutrition resulted
in an increase in total fat mass in female, but not male lambs
[49]. Interestingly, maternal dietary restriction imposed in
the overnourished ewe during the periconceptional period
ablated the development of an increase in total body fat
in the female lambs (Figure 2). There was also a signiﬁcant
relationship between the total fat mass of female lambs at 4
monthsofageandtheweightofthedonoreweatconception.
The greatest impact of periconceptional overnutrition was
on the perirenal and omental fat depots in the female lamb
and the weights of these depots were also higher in female
thanmalelambsinallnutritionalgroups.Thegreaterimpact
of periconceptional overnutrition in the female lamb, may
be related to the higher level of expression of adipogenic and
lipogenic genes, for example, G3PDH and lipoprotein lipase
(LPL) present in adipose tissue in female, compared to male
lambs.
Exposure of the oocyte and early embryo to a high plane
ofmaternalnutritionthereforeresultedinagreaterpostnatal
capacity to synthesise and store triglycerides in female lambs.
We have speculated that the early embryo may respond to
maternalovernutritiontoprogramchangeswithinmetabolic
pathways which ultimately result in a more eﬃcient deposi-
tionoffatinvisceralfatdepotsinpostnatallife.Itmaybethat
this early response is on the basis that the postnatal nutri-
tional environment will match the high nutritional envi-
ronment experienced by the embryo and that an increased
capacity to store fat will be required in postnatal life.
Interestingly we found that there was no eﬀect of
periconceptional overnutrition on the level of expression of
PPAR γ, leptin, and adiponectin in the perirenal, omental, or
subcutaneous fat depots in lambs at 4 months of age [49].
Thus, exposure of the sheep embryo to periconceptional
overnutrition results in an increased visceral adiposity with
no increase in adipose PPAR γ or leptin expression, whereas
exposure to maternal overnutrition in late gestation results
in an increase in PPAR γ and leptin expression in fetal
visceral fat and an increase in subcutaneous fat mass in
postnatal life. These diﬀerences may reﬂect diﬀerences in
timing between the study endpoints (4- versus 1-month
postnatal age, resp.), or it may be that diﬀerent signalling
systemsareactivatedinadipocytesafterexposuretomaternal
overnutrition during the periconceptional and late gesta-
tional periods. Periconceptional overnutrition may result
in epigenetic changes induced in the germ layers of the
embryo associated with an increase in the diﬀerentiation,
proliferation, and/or hypertrophy of visceral adipocytes.
Thus, the early programming of later obesity may result
from “two hits,” the ﬁrst occurring as a result of maternal
overnutrition during the periconceptional period and the
second occurring as a result of increased fetal nutrition in
late pregnancy [51].
5.2.3. Dietary Intervention during the Periconceptional Period:
Metabolic Beneﬁts. As noted above, we found that placing
the obese ewe on a dietary regime where the energy intake
was reduced to 70% of normal for one month before and
one week after conception only resulted in an ablation of the
eﬀects of maternal overnutrition on the total fat mass in the
femalelamb[49].Thisisanimportantﬁndingasithighlights
that nutritional intervention in the periconceptional period
canablatetheeﬀectsofahighmaternalprepregnancyweight
on oﬀspring adiposity. One issue, however, is whether such a
dietary restriction regime has any other positive or negative
metabolic or endocrine consequences for the oﬀspring.
5.2.4. Dietary Intervention during the Periconceptional Period:
Metabolic and Endocrine “Costs”. It has previously been
shown that a severe nutritional restriction imposed in ewes
with a body weight in the normal range across both the
periconceptional and early gestation periods (from 60 days
before until 30 days after mating) resulted in a decreased
glucose tolerance in the 10-month-old oﬀspring [45]. In
this latter study, this period of undernutrition resulted in an
increase in the glucose and insulin areas under the curve in
response to a glucose tolerance test at 4 and at 10 months
postnatal age [45]. It is not known, however, whether a
similar period of dietary restriction in obese ewes would
have similar metabolic consequences in the oﬀspring. It has
also been demonstrated that moderate dietary restriction
imposed during the periconceptional period results in an
increase in fetal arterial blood pressure and in an earlier
activation of the fetal prepartum cortisol surge [52, 53].
We have recently determined whether exposure to a
moderate restriction of energy intake in obese and normal
weight ewes results in changes in the development of the
hypothalamo-pituitary-adrenal axis and the stress response
in the oﬀspring. We have found that dietary restriction
imposedduringthepericonceptionalperiodineithernormal
w e i g h to ro b e s ee w e sr e s u l t e di na ne n h a n c e dc o r t i s o l
response to stress in female lambs at 3-4 months of age6 Experimental Diabetes Research
40
50
60
70
80
D
o
n
o
r
w
e
i
g
h
t
(
k
g
)
P C O N( H H ,H R )
Dietary restriction
(CR, HR) Conception
(0)
∗ ∗ ∗ ∗ ∗ ∗ ∗
∗ ∗
∗ ∗
∗ ∗ ∗
∗
∗ ∗ ∗
∗
∗
∗ ∗
−35 −31 −29 −27 −25 −23 −20 −17 −15 −13 −11 −9 −7 −5 −3 −1 1
Weeks relative to conception (0)
CC donor
CR donor
HH donor
HR donor
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Figure 2: Eﬀect of periconceptional overnutrition and/or dietary
restriction on the total fat mass of female lambs at 4 months of age
(CC:openbar;CR:stripedbar;HH:greybar;HR:greystripedbar).
Diﬀerent superscripts (e.g., a, b) denote a signiﬁcant diﬀerence of
total fat mass between the treatment groups (P<0.05) (reprinted
from Rattanatray et al. 2010 [49]).
(Figure 3)[ 50]. In this study, the adrenal gland was also
bigger at 4 months of age in male and female lambs which
were conceived in either normal weight or obese ewes which
had been exposed to dietary restriction during the peri-
conceptional period. The increase in adrenal growth was
associated with a decrease in the adrenal expression of the
insulin-like growth factor 2 (IGF 2). IGF2 is expressed
in a parent-of-origin-speciﬁc manner from the paternal
gene and has been implicated in the regulation of adrenal
growthandsteroidogenesisinthefetalsheep[54].Epigenetic
modiﬁcations play a vital role in the transmission of the
parental identity of particular alleles through the germline;
this is achieved through complex mechanisms typiﬁed by
cytosine methylation of “imprinting control regions” (ICR).
For IGF2, the ICR resides within a diﬀerentially methylated
region (DMR) 4kb upstream of the neighbouring nonpro-
tein coding H19 gene. When the DMR is methylated, IGF2
is expressed, and conversely when the DMR is unmethylated,
IGF2 expression is repressed by H19 [55]. Using combined
bisulphite restriction analysis (COBRA), we found that the
lamb adrenals in the CR group carried signiﬁcantly less
methylation in the IGF2/H19 DMR when compared to the
CC and HH groups, and this eﬀect was present in both
male and female lambs [50]. Bisulphite sequencing of a
subset of animals from each group revealed that the loss of
methylation observed in the CR group was marked, with
most animals exhibiting a complete loss of methylation. It
wasalsoofnotethatsomeanimalsintheHRgroupexhibited
loss of IGF2/H19 DMR methylation. Thus, the increase in
adrenal weight in the CR and HR lambs was paradoxically
associated with a decrease in the expression of an adrenal
growth factor which in turn was associated with decreased
level of methylation in the proximal CTCF binding site in the
DMR region of the IGF2/H19 gene in these groups. There
was no change, however, in the methylation status of IGF2R
or in IGF2R mRNA expression in the adrenals of the lambs
in either the CR or HR groups. It remains to be determinedExperimental Diabetes Research 7
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Figure 3: Relative adrenal weight (a) in the CC, CR, HH, and HR lambs (CC: open bar; CR: striped bar; HH: grey bar; HR: grey striped
bar), plasma cortisol concentrations (b) in response to stress in female lambs at postnatal week 12, adrenal IGF2 mRNA expression (c), and
IGF2/H19 DMR methylation levels (d) in lambs at postnatal week 16 (from Zhang et al., 2010 [50]). Diﬀerent superscripts a, b, and c denote
treatment groups which are signiﬁcantly diﬀerent from each other (P<0.05).
Weighing up the potential beneﬁts and costs
of maternal weight loss during the periconceptional period
Potential metabolic beneﬁts Potential metabolic costs
Before birth
Improved glucose
tolerance
↓Adipose tissue
mass
↓Adipose tissue
mass
Earlier activation of
prepartum cortisol
surge
↑Arterial blood
pressure
Before birth
Insulin resistance
↑Stress response
↑Activation of the
HPA axis
Child- and
adulthood
Child- and
adulthood
Figure 4: Diagram summarising the potential beneﬁts and costs of maternal weight loss during the periconceptional period.8 Experimental Diabetes Research
whether the decrease in adrenal IGF2 mRNA expression is
a consequence of the epigenetic changes in adrenal IGF2 or
whether there are other factors driving adrenal growth in
these animals which in turn suppress IGF2 gene expression
within the adrenal. It has recently been reported that people
whose mothers were exposed to famine during the Dutch
Hunger Winter in 1944-1945 had less IGF2 methylation in
blood cells in adult life compared with their unexposed
same-sex siblings [56]. In particular, epigenetic changes were
found among individuals who had been exposed to famine
in early gestation and who had a normal birth weight. In
contrast, exposure to famine in late gestation was associated
with a low birth weight, but not with epigenetic changes in
the blood cells in later life [56].
Thus, studies on the eﬀects of maternal undernutrition
imposed during the periconceptional period highlight the
need to be cautious about the level and length of any dietary
intervention regime imposed around the time of conception
as not all of the metabolic and endocrine eﬀects of dietary
restrictioninthisperiodmaybebeneﬁcialinthelongerterm.
Thus, there appear to be a series of changes including
epigenetic modiﬁcations in a number of key genes induced
in the embryo after exposure to either maternal over-
or undernutrition. These may result in metabolic and
endocrine changes which result in responses consistent with
the expectation of either a “life of adversity” or of a “life
of plenty” with high levels of postnatal nutrition. Critically,
there is evidence that metabolic and endocrine changes may
beinducedinoﬀspringafterimpositionofdietaryrestriction
during the pre pregnancy period in either normal weight
or obese mothers. This is important in the context of the
dietary advice given to overweight or obese women who are
seeking to become pregnant as it is critical that any dietary
intervention imposed during the periconceptional period is
evidence based and does not incur a further metabolic or
endocrine cost in the oﬀspring.
6. Summary
It is clear that further work is required to determine
the separate or interdependent contributions of maternal
pre pregnancy BMI and gestational weight gain, glycaemic
control, and macronutrient intake during pregnancy on
the metabolic outcomes in the oﬀspring. It appears from
recent studies in the sheep that the early programming
of later obesity may result from “two hits” related to the
separate inﬂuences of maternal obesity experienced during
the periconceptional period and during late gestation. Each
of these exposures may act through diﬀerent mechanisms
to alter the propensity for triglyceride storage in speciﬁc fat
depots after birth. While a period of dietary restriction in
overweight mothers may ablate the impact of maternal BMI
on the programming of postnatal obesity, it is associated
with an activation of the stress axis and a potential impact
on glucose tolerance in the oﬀspring (Figure 4). Thus, a
high maternal pre pregnancy BMI may result in epigenetic
changes within the embryo which predict the need for
eﬃcient fat storage in postnatal life. In contrast, weight loss
in mothers with either a high or normal BMI may lead to
epigenetic changes within the stress axis which predict the
likely need to respond to adversity in later life. Thus, it is
importanttoensurethatanydietaryrestrictioninterventions
recommended for overweight or obese mothers are evidence
based to allow an eﬀective weighing up of the potential
metabolic beneﬁts and costs (Figure 4) for the oﬀspring.
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